Start Submission Become a Reviewer

Reading: Brugada Syndrome


A- A+
Alt. Display

Review Articles

Brugada Syndrome


Ramon Brugada ,

University of Girona-IDIBGI, Girona, ES
About Ramon
M.D., Ph.D.
X close

Oscar Campuzano,

University of Girona-IDIBGI, Girona, ES
About Oscar
B.Sc., Ph.D.
X close

Georgia Sarquella-Brugada,

Hospital Sant Joan de Deu, University of Barcelona, Barcelona, ES
About Georgia
X close

Josep Brugada,

Hospital Clinic Barcelona, University of Barcelona, Barcelona, ES
About Josep
M.D., Ph.D.
X close

Pedro Brugada

UZ Brussel-Vrije Universiteit Brussel, Brussels, BE
About Pedro
M.D., Ph.D.
X close


Brugada syndrome is a rare cardiac arrhythmia characterized by electrocardiographic right bundle branch block and persistent ST-segment elevation in the right precordial leads. It is associated with ventricular fibrillation and a high risk for sudden cardiac death, predominantly in younger males with structurally normal hearts. Patients can remain asymptomatic, and electrocardiographic patterns can occur both spontaneously or after pharmacological induction. So far, several pathogenic genes have been identified as associated with the disease, but SCN5A is the most prevalent one. Two consensus reports to define the diagnostic criteria, risk stratification, and management of patients have been published in the last few years. This brief review focuses on the recent clinical diagnosis, genetic basis, and advances in pharmacological treatment of Brugada syndrome.

How to Cite: 1. Brugada R, Campuzano O, Sarquella-Brugada G, Brugada J, Brugada P. Brugada Syndrome. Methodist DeBakey Cardiovascular Journal. 2014;10(1):25-28. DOI:
Published on 01 Jan 2014.
Peer Reviewed


  • PDF (EN)